2 results
Approved WMOCompleted
To determine the efficacy of the combinations of retifanlimab + INCAGN02385 (TG2) and retifanlimab + INCAGN02385 + INCAGN02390 (TG3) compared with retifanlimab alone (TG1) in the overall study population.
Approved WMOPending
Primary objective:• To assess the clinical safety and effectiveness of Pulse Rate (PR) and Respiration Rate (RR) measuredwith the VSC-MEDlib within the intended use compared to the gold-standard reference devices.Exploratory objective:• To assess…